Axon part (GO:0033267) |
32/415 |
0.003757 |
CHD-type complex (GO:0090545) |
4/18 |
0.008459 |
Cytoplasmic ribonucleoprotein granule (GO:0036464) |
23/268 |
0.003642 |
Early endosome (GO:0005769) |
34/434 |
0.002231 |
NuRD complex (GO:0016581) |
4/18 |
0.008459 |
PML body (GO:0016605) |
13/113 |
0.002301 |
Postsynaptic density (GO:0014069) |
25/35 |
0.006811 |
Ribonucleoprotein granule (GO:0035770) |
23/281 |
0.006435 |
Transcription factor complex (GO:0005667) |
33/403 |
0.001257 |
Transcriptional repressor complex (GO:0017053) |
11/90 |
0.003031 |
Appendage development (GO:0048736) |
23/188 |
0.000026 |
Axonogenesis (GO:0007409) |
46/498 |
0.000010 |
Cell fate commitment (GO:0045165) |
34/304 |
0.000003 |
Embryonic organ development (GO:0048568) |
43/480 |
0.000041 |
Limb development (GO:0060173) |
23/188 |
0.000026 |
Lung development (GO:0030324) |
23/193 |
0.000040 |
Positive regulation of neuron differentiation (GO:0045666) |
41/402 |
0.000003 |
Positive regulation of neuron projection development (GO:0010976) |
32/304 |
0.000018 |
Regulation of cellular component size (GO:0032535) |
39/407 |
0.000021 |
Regulation of transcription involved in cell fate commitment (GO:0060850) |
7/18 |
0.000010 |
DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228) |
46/479 |
0.000009 |
GTP binding (GO:0005525) |
33/406 |
0.002841 |
Guanyl nucleotide binding (GO:0019001) |
35/429 |
0.002028 |
Guanyl ribonucleotide binding (GO:0032561) |
35/429 |
0.002028 |
Nucleoside binding (GO:0001882) |
33/422 |
0.005119 |
Purine nucleoside binding (GO:0001883) |
33/414 |
0.003839 |
Purine ribonucleoside binding (GO:0032550) |
33/411 |
0.003434 |
Ribonucleoside binding (GO:0032549) |
33/415 |
0.003982 |
SUMO transferase activity (GO:0019789) |
5/20 |
0.002265 |
Transcription corepressor activity (GO:0003714) |
22/195 |
0.000214 |